The growing investments in the healthcare sector will likely create several opportunities for key players in the industry. The prospective advancement of the industry is vastly dependent on the growth of leading players, and hence, this will be the decisive factor in determining the upliftment of the sector.

WILMINGTON, Del., July 17, 2024 /PRNewswire/ -- The projected size of the global cholesterol testing product market will reach USD 49.4 billion by 2034, which will be lifted from USD 21.8 billion, measured in 2023. This development will occur at a moderate to impressive CAGR of 7.8% through the forecasted period.

With the growing proportion of obese population across the world, the rate of heart issues is growing. People have been struggling to ensure the well-being of the heart, which drives the demand for suitable measures to arrest such issues.

The demand from medical professionals will likely increase due to the increased number of patients visiting clinics or hospitals for check-ups. This is a key driver for the industry, elevating the growth rate of the sector.

The growing prevalence of cardiovascular diseases will likely spur the demand for accurate diagnosis and medical examination of individuals to reduce as well as control the threat of heart failure. As a result, the cholesterol testing products will likely gain traction in the industry, upscaling the market.

Find an overview of this report in sample report available in PDF format: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86118 

With the increasing obese population in the world, the proportion of cholesterol accumulation along blood vessels will spur. This threatens people with several heart-related issues, affecting the quality of life of individuals. The demand for cholesterol testing products, therefore, will likely elevate, driving the growth rate of the industry.

The initiatives of governments have helped the healthcare industries in different countries to become robust. This creates various opportunities for key players in the industry to explore different market openings. The scope of innovation also spurs, inducing a chance for reduced costs of devices, pushing the growth of the industry.

Key Findings from the Market Report

• With the cholesterol testing product market being divided into many key segments, the product type segment will likely gain the highest traction. Test kits are an integral part of the segment, which is gaining popularity in a wide age group range. The easy usability and better reliability of such test kits uplift the demand.
• To calculate the total cholesterol accumulated in the blood vessels, many patients prefer total cholesterol tests. This segment, hence, is expected to gain traction during the forecasted period.
• With the growing investments in the healthcare infrastructure, the total number of hospitals worldwide is expected to spur. This will likely surge the demand in the segment, helping the end-user contribute significantly to the growth of the industry.
• Similar to hospitals, private diagnostics centers are also increasing, which drives the demand for test kits in such centers.

Cholesterol Testing Product Market Report Scope:

Regional Profile

• The healthcare infrastructure in North America is better. Countries like Canada and the United States have robust healthcare support, creating lucrative growth prospects for key players.
• In the case of Europe, government investments in the healthcare sector and the nationalized healthcare services in countries like the United Kingdom (NHS) will help the region contribute substantially to the development of the market.
• With the growing population in Asia-Pacific, the demand for check-ups will likely spur. This will elevate the contribution of the region during the forecasted era.

Request a PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86118 

Key Developments in the Cholesterol Testing Product Market

• In November 2023, Ngaio Diagnostics collaborated with Randox. The said initiative helped the latter business to bring products to the New Zealand market.
• In January 2024, Abbott Laboratories launched PROTALITY. The brand promises to provide nutritional support for adults who are in the pursuit of weight loss.

Competitive Landscape

The global cholesterol testing product market is highly cluttered. Different key players occupy a substantial market space, governing the competitive landscape. Athenese-Dx Private Limited is a key competitor in producing Alta semi-auto chemistry analyzers, Alta rapid test readers, Alta ELISA plate readers, and many more.

• Ngaio Diagnostics is another key player that manufactures mini digital incubators, AxCCS-5 rapid calf scour test kits, campylobacter latex, and so on.
• Abbott Laboratories operates in different verticals and produces cardiovascular devices, neuromodulator kits, and various diagnostics units.

Key Players

• Athenese-Dx Private Limited
• Ngaio Diagnostics
• Abbott Laboratories
• Thermo Fisher Scientific
• Biogenix Inc. Pvt. Ltd.
• CLIAwaived Inc
• F. Hoffmann-La Roche Ltd.
• PerkinElmer Inc.
• Randox
• Abcam Limited
• Diazyme Laboratories Inc.
• Others

Market Segmentation

Product Type

• Test Kits
• Test Strips
• Chemical Analyzers

Test Type

• Total Cholesterol Test
• High-density lipoprotein (HDL) Cholesterol Test
• Low-density lipoprotein (LDL) Cholesterol Test
• Triglycerides/Very-Low-Density Lipoprotein (VLDL) Cholesterol Test

End User

• Hospitals & Clinics
• Diagnostic Centers
• Others (Research Institutes, etc.)

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.transparencymarketresearch.com/checkout.php?rep_id=86118&ltype=S 

Have a Look at Latest Reports of Healthcare Domain:

• Dental Syringe Market - The global market for dental syringes was estimated to be worth a market valuation of US$ 343.4 million in 2021. The market is anticipated to advance with a steady 5.1% CAGR from 2022 to 2031 and by 2031, the market is likely to gain US$ 577.8 million.
• Blood Testing Market - The global market is anticipated to rise from US$ 80.2 Bn in 2021 to US$ 218.2 Bn by 2032. The research study projects that the global industry for blood testing solutions is likely to expand at a CAGR of 9.6% between 2022 and 2032.
• Fibromyalgia Treatment Market: Fibromyalgia Treatment Market to grow at a CAGR of 3.8% from 2024 to 2034 and reach US$ 2.9 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/cholesterol-testing-products-market-worth-us-49-4-billion-by-2034--exclusive-report-by-transparency-market-research-inc-302198520.html